Veterinary Medicine Information website

Ultrasan vet. Injektionsvätska, lösning

Not authorised
  • D ALPHA TOCOFERIL ACETATE
  • Retinol palmitate
  • Ergocalciferol

Product identification

Medicine name:
Ultrasan vet. Injektionsvätska, lösning
Active substance:
  • D ALPHA TOCOFERIL ACETATE
  • Retinol palmitate
  • Ergocalciferol
Target species:
  • Cattle
  • Dog
  • Horse
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • D ALPHA TOCOFERIL ACETATE
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    100000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Ergocalciferol
    50000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        259
        day
      • Milk
        120
        hour
    • Horse
      • Meat and offal
        243
        day
    • Sheep
      • Meat and offal
        194
        day
      • Milk
        120
        hour
    • Pig
      • Meat and offal
        243
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Authorisation status:
  • Surrendered
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pharmaxim AB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 6645
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 29/07/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 29/07/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 29/07/2022